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Epidemiological studies suggest an inverse association between folic acid intake and colorectal cancer risk. Conversely, conventional treatment of
existing tumours includes the use of folate antagonists. This suggests that the level of exposure to folate and its timing in relation to stage of
tumorigenesis may be critical in determining outcomes. We hypothesised that folic acid depletion in utero and during early neonatal life may
affect tumorigenesis in offspring. To investigate this hypothesis, female C57Bl6/J mice were randomised to a folic acid adequate (2 mg folic
acid/kg diet) or folic acid depleted diet (0·4 mg folic acid/kg) from mating with Apc þ/Min sires and throughout pregnancy and lactation. At weaning
the Apc þ/Min offspring were randomised to a folic acid adequate (2 mg folic acid/kg diet) or depleted (0·26 mg folic acid/kg diet) diet, creating four
in utero/post-weaning dietary regimens. At 10 weeks post-weaning, mice were killed and the intestinal tumour number and size were recorded.
Folic acid depletion during pregnancy and post-weaning reduced erythrocyte folate concentrations in offspring significantly. Folic acid depletion
during pregnancy and lactation did not affect tumour multiplicity or size. However, female mice fed normal folic acid diets post-weaning had
more, and larger, tumours when compared with depleted females and both depleted and adequate folic acid fed males. These data suggest that
folate depletion post-weaning was protective against neoplasia in female Apc þ/Min mice and highlights the need for further investigation of the
optimal timing and dose of folic acid supplementation with regard to colorectal cancer risk.
Folate: Intestinal tumours: Gender: In utero
Variation in diet and nutritional factors contribute about
50 % of variability in risk of developing colorectal cancer
(CRC) in Westernised countries1. Efforts have been focused
on understanding the dietary factors that influence CRC
development. Substantial epidemiological evidence indicates
that low folate intake or status is associated with increased
risk of CRC2 – 5 but this association is not consistent and
some studies have failed to demonstrate a relationship6,7.
The main metabolic role of folate is to carry one carbon
unit8 and, as such, folate is an essential cofactor in the
purine and thymidylate synthesis and in the methylation of
biological molecules, e.g. DNA. Due to evidence that loss
of genomic integrity is fundamental to tumour development9
a plausible case can be made that folate status may impact
upon carcinogenesis. Aberrations in DNA synthesis, stability
and repair due to a lack of folate have been associated with
increased mutations, DNA strand breaks and impairments in
DNA repair ability, all of which could increase the risk of
neoplasia10. In addition, alterations in DNA methylation pat-
terns have been reported in tumours at many sites including
the colorectum11. Since DNA methylation is an important
epigenetic determinant of gene expression, aberrations may
lead to incorrect transcriptional control and thus increase
tumour risk12. Aberrant DNA methylation also plays a role
in the development of mutations, as well as affecting
DNA integrity, DNA stability and chromosomal modifi-
cations12.
Some human epidemiological studies support the hypoth-
esis that supplemental folate, usually provided as folic acid,
is protective against CRC development2,13 – 15, but the evi-
dence is equivocal and uncertainty remains about the
effects of enhanced folic acid intake on CRC develop-
ment16. Moreover, experiments using animal models have
uncovered conflicting evidence about the relationship
between folate supply and intestinal carcinogenesis. Cravo
et al.17 reported that moderate folate deficiency non-signifi-
cantly enhanced the development of neoplasia in the colon
of 1,2 dimethylhydrazine (DMH)-treated rats and Kim
et al.18 reported that supplementation with folate conferred
protection against the development of microscopic to
macroscopic foci in the same model. Furthermore, increased
numbers of aberrant crypts have been observed in DMH-
treated rats fed a folate-free diet compared with animals
fed a normal folate diet (2 mg folic acid/kg diet)19. Feeding
a folate-free diet to rats exposed to the mutagen tribromo-
methane in drinking water significantly increased aberrant
crypt foci when compared with tribromomethane-exposed
rats fed a normal folate diet (2 mg/kg)20. In contrast, in
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azoxymethane-treated rats, Le Leu et al.21 reported that a
folate-free diet reduced the development of colonic aberrant
crypt foci over 12 weeks and reduced tumour number in
the small and large intestine over 26 weeks compared
with rats fed 8 mg folic acid/kg diet22. In adult Apc þ/Min
mice, which develop multiple intestinal neoplasms spon-
taneously, Song et al.23 reported a protective effect of
folate against small intestinal tumours, which was dose-
dependent. In contrast, Sibani et al.24 observed fewer
tumours in Apc þ/Min mice fed a diet deficient in folate
and choline. Given the key role of folate in one carbon
metabolism and cell division, it is conceivable that extra
folate could enhance the growth of in situ tumours.
Indeed, in the Apc þ/ –Msh2 – /– mouse, timing of folate
supplementation was found to be critical to its effect
upon tumorigenesis25. In mice given a folate-supplemented
diet (8 mg folic acid/kg diet) from 3 weeks of age, intesti-
nal and colonic adenomas were 2·7- and 2·8-fold lower
than in folate-depleted mice (0 mg folic acid/kg diet). How-
ever, when folate was supplemented from 6 weeks of age,
mice had 4·2-fold more small intestine (SI) adenomas than
folate-depleted mice. Therefore, the protective (or other-
wise) effects of folate in colorectal carcinogenesis remain
to be characterised, with the likelihood that dose and
timing may be critical to potential chemopreventative out-
come.
Adequate folate supply is important during pregnancy.
Moderately folate-deficient rats have a reduced litter size
and birth weight compared with normal folate animals and
severely deficient rats have an increased risk of fetal
demise26. Folate deficiency during embryonic development
caused increased rates of fetal resorption, malformations
and post-partum death in mice27. Although the role of
folate in spontaneous abortion in human females remains
to be ascertained, low folate intake has been associated
with low birth weight in human newborns28 and the ben-
eficial effect of supplemental folic acid in the prevention
of neural tube defects is well documented29. Maternal nutri-
tion post-partum is also important for the developing infant.
Infant plasma folate concentration has been correlated
directly with levels of folate in breast milk30 and, although
folate is taken up preferentially by the actively secreting
mammary gland, a severe maternal deficiency could affect
folate supply to the infant31. Maternal folate deficiency in
rats has been associated with poor growth of pups during
lactation32.
There is increasing evidence to support the developmental
origins of adult disease theory, in which it is hypothesised
that exposures during early life may contribute to risk of
disease in adulthood. The association between birth weight
and adult diseases (such as type 2 diabetes, CHD and hyper-
tension) has been attributed to poor nourishment in utero,
under which condition the fetus adapts to enhance survival
by altering metabolism and reducing body size33. The
effects upon adult health may be due to the mechanisms
that are used to convey these changes in the fetus. Given
that increased incidence of CRC has been associated with
low dietary folate status and that early life nutrition has a
substantial influence on adult health, we hypothesised that
folic acid depletion in utero and pre-weaning could affect
tumorigenesis in adult Apc þ/Min mice.
Materials and methods
Animal housing, husbandry and diets
Mice were housed in the Comparative Biology Centre
(Newcastle University) at a temperature of 20–228C and
with 12 h light and 12 h dark cycles. Fresh water was available
ad libitum. Experimental diets were based on the AIN-93G34
and contained 0·26, 0·4 or 2 mg folic acid/kg diet. The 2 mg
folic acid/kg diet was the control diet (containing the concen-
tration of folic acid considered normal for rodents34) and the
folic acid content was provided by the AIN93VX vitamin
mix. The lower folic acid diets were prepared using a folic
acid-free AIN93VX vitamin mix to which the appropriate
amount of folic acid was added. The 0·4 mg folic acid/kg
diet was fed to dams to induce folic acid depletion during
pregnancy and lactation, whilst the 0·26 mg folic acid/kg
diet was used to induce depletion of folic acid status in
weaned mice as evidenced by significantly reduced erythro-
cyte (RBC) folate concentration.
Two C57BL/6J (Black 6) female mice were mated with
each Apc þ/Min male. Breeding mice were offered an exper-
imental diet (6 g/d) containing either a normal folic acid
(2 mg/kg) or depleted folic acid (0·4 mg/kg) concentration.
Once females were observed to be pregnant (by presence of
a vaginal plug and/or swollen abdomen) they were re-caged
and the quantity of food offered was increased to 10 g/d.
At 2 weeks post-partum, the diet was further increased to
20 g/d to ensure sufficient food supply for weanling pups
and for the lactating female.
Sub-sets of pups and all dams were killed at weaning (mean
32 d post-partum). Blood was collected by cardiac puncture
for RBC folate analysis and the intestines of the pups were
weighed and measured. Following genotyping, the remaining
offspring were re-caged (one to four animals per cage) and
assigned at random to the normal (2 mg/kg) or depleted
(0·26 mg/kg) folic acid diet (6 g/d). This resulted in four diet-
ary intervention groups of adult offspring: normal folic acid
pre- and post-weaning (NN); depleted folic acid pre- and
post-weaning (DD); normal folic acid pre-weaning followed
by depleted folic acid post-weaning (ND); depleted folic
acid pre-weaning followed by normal folic acid post-weaning
(DN). Body weights of animals were recorded weekly post-
weaning. Folic acid depletion did not alter growth weights
of animals compared with controls. After an average of 70 d
on the post-weaning experimental diets, 148 mice (thirty-
seven per treatment group) were killed for sample collection.
Genotyping
Pups were genotyped at a mean age of 29 d by a standard PCR
procedure (using DNA extracted from a tail biopsy) followed
by restriction digest35.
Sample collection and analysis of gut tumours
Animals were anaesthetised using gaseous isoflurane. Blood
was collected by cardiac puncture into an EDTA collection
tube and protected from light. Total body, liver, SI, colon
and caecum weights were recorded and the lengths of the SI
and colon were measured. The SI was cut into two equal sec-
tions, the proximal and the terminal SI. The SI sections, colon
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and caecum were opened longitudinally and washed with PBS.
Tumour size and location were recorded by a study-blinded
technician.
Erythrocyte folate analysis
RBC folate concentrations were measured in haemolysate by
the automated ion capture assay using the IMX folate
system (Abbot IMx; Abbot Laboratories) as described by
Basten et al.36.
Statistical analysis
The effects of experimental diet were examined by ANOVA
according to a 2 £ 2 factorial design (maternal and weaning
folate supply) with gender of mouse as a fixed effect factor.
Results
Effects of folic acid depletion on pregnancy outcome
Litter sizes of dams fed the depleted folic acid diet were
reduced by 22 % (P¼0·006) compared with their normal
folic acid counterparts, but there was no effect of feeding
the folic acid-deplete diet on survival of pups during lactation.
With both diets there was a slight excess (59 %) of males and
no difference in the proportion of offspring carrying the Min
genotype from folic acid-depleted compared with folic acid-
normal dams (55 and 49 % respectively).
Effects of pre- and post-weaning folic acid depletion upon
growth and organ dimensions
At weaning, pups from folic acid-depleted mothers were
approximately 7·5 % lighter (P¼0·093) than controls but
there were no significant (P.0·05) effects of maternal folic
acid supply on intestinal organ weights or organ lengths of
pups at weaning (data not shown).
After 70 d of feeding the experimental diets to the offspring,
there was little evidence of any gross differences in body size
or in intestinal organ dimensions (Table 1). The exception was
colon length, which was significantly (P¼0·03) greater in
mice born to folic acid-depleted dams.
Effects of pre- and post-weaning folic acid depletion upon
erythrocyte folate status of weaned and adult Apcþ/Min
offspring
At weaning, the offspring of the dams fed the low folic acid
diet had significantly (P¼0·011) lower RBC folate concen-
tration than the offspring of dams fed the normal folic acid
diet (Fig. 1(A)). However, maternal folic acid depletion had
no significant effect upon RBC folate concentrations in adult
offspring (Fig. 1(B)). As expected, RBC folate concentration
was reduced significantly (P,0·001) in mice fed the depleted
folic acid diet from weaning (Fig. 1(C)).
Effects of pre- and post-weaning folic acid depletion on
tumour number and size in Apc1/Min mice
Tumour diameters ranged up to 10 mm with a mean of 1·8 mm
and median 1·6 mm. On this basis, tumours 1 mm and under
were classified as ‘small’ and those diameters over 1 mm
being ‘large’. The majority of tumours were found in the
distal SI, regardless of dietary treatment (Table 2). In addition,
small tumours made up a higher proportion of the total tumours
in the distal SI when compared with the proximal SI and the
colon (Table 2). There was no evidence that maternal folic
acid depletion had any effect on total number, anatomical distri-
bution or size of intestinal tumours (Table 2). In contrast, feed-
ing the low folic acid diet to the weaned offspring resulted in
fewer total gut tumours, with effects being concentrated in the
distal half of the SI, but these differences were not statistically
significant (P.0·05) (Table 2).
Since smaller adenomatous polyps are less likely to develop
into carcinomas in human subjects37, the effect of dietary
interventions on the size distribution of intestinal tumours
was investigated by calculating the percentage of small
(#1 mm in diameter) tumours. This showed clearly that
there was a greater proportion of small tumours in the gut
of animals weaned on to the low folic acid diet (P¼0·028)
with this reduction in tumour size being most apparent in
the distal SI (P¼0·023) (Table 2).
Female mice had nearly twice as many intestinal tumours as
male mice (Fig. 2) due to significantly more SI tumours
(P¼0·041) with no difference in colonic tumours
(P¼0·322). Accordingly, gender was included as a fixed
factor in the statistical analysis of the tumour data (Table 2).
Overall tumour burden, calculated as the total diameter of
all gut tumours, was also higher in females, (29·6 mm com-
pared with 17·6 mm for males) (P¼0·056).
Further inspection of the tumorigenesis data (Fig. 3)
revealed significant (P,0·05) differences in the responses
of male and female mice to altered folic acid supply post-
weaning. In male mice, reduced folic acid intake from wean-
ing had no effect on total tumour multiplicity, SI tumour
numbers, tumour burden or percentage of small tumours
(Fig. 3(A)–(D)). In contrast, the low folic acid diet suppressed
total and SI tumour number and tumour burden in female mice
compared with females given a normal folic acid diet
(Fig. 3(A)–(C)), so that females fed the folic acid-restricted
diet had similar tumour numbers to males. However, the pro-
portion of small tumours in females increased to almost twice
that seen in males when the low folic acid diet was offered
from weaning (Fig. 3(D)).
Discussion
As expected, in the present study, dietary folic acid depletion
decreased RBC folate in both dams and weaned offspring.
However, adult offspring exposed to maternal folic acid
depletion did not have reduced RBC folate status, indicating
that early folic acid depletion is not detrimental to RBC
folate status in later life. Note that RBC folate concentrations
in this study were higher than values described by Bird et al.38
as being typical for mice and also higher than those reported
by McDorman et al.39 for mice fed adequate (5 mg folic
acid/kg diet) or depleted (0 mg folic acid/kg) diets. In part,
J. A. McKay et al.552
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these differences are due to the significantly lower haematocrit
values for Apc þ/Min than wild-type mice (data not shown).
Folic acid depletion during pregnancy affected pregnancy
outcome by significantly lowering the mean number of pups
per litter. This effect of reduced maternal folate supply has
been seen previously in rodents26 and may be due to theT
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Fig. 1. Effects of pre- and post-weaning folate diets upon mean erythrocyte
(RBC) folate concentrations. Error bars represent 95 % CI. (A) Mean RBC
folate of weanling pups of dams fed normal and depleted folate diets, (n 8 for
both diet groups; *P¼0·011); (B) mean RBC folate of adult offspring exposed
to normal and depleted folate diets pre-weaning (n 28 and 24 respectively).
Data for animals fed both normal and low folate diets from weaning have
been pooled since there was no evidence for a maternal £ weaning diet inter-
action; (C) mean RBC folate of adult offspring fed normal and depleted folate
diets post-weaning. (n 25 and 27 respectively; *P¼,0·001). Data for animals
from dams fed both normal and low folate diets have been pooled since
there was no evidence for a maternal £ weaning diet interaction. For details
of diets and procedures, see Materials and methods.
Gender specific modulation of tumorigenesis 553
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
lack of folate required for DNA synthesis and therefore
restricting cell division. Folate deficiency during pregnancy
can cause fetal death and resorption, depending upon severity
and length of the nutritional insult40. For example, mice given
a folate-depleted diet and the antibiotic succinyl sulfathiazole,
which reduces synthesis of folate by gut bacteria, from 4
weeks prior to mating had an increased incidence of resorp-
tions at gestation days 11/12, 13–16 and 18 compared with
mice given normal folate diets with and without succinyl sul-
fathiazole27. During the present study, fetal resorption was not
investigated but is a possible mechanism for the reduced litter
size with folic acid depletion. Although litter size was reduced
by folic acid depletion during pregnancy, there was no prefer-
ential selection of either gender or genotype of the resultant
litters from dams fed folic acid-depleted diets. In a recent
study, maternal folate status was positively associated with
infant birth weight in human subjects41. Although maternal
folic acid depletion had no significant effect upon body
weight or organ weights or lengths in either dams or offspring
killed at weaning, it led to increased colon weight and length
in adult mice. It has been hypothesised that nutrient
deficiencies during development prepare the fetus for future
harsh environments in which it may be subjected to further
nutrient depletion42. Indeed, intrauterine growth retardation
has been documented to restrict growth of the rat SI43, ovine
pancreas44 and human liver and kidney45, whilst nutrient restric-
tion during pregnancy lowered kidney weight in rats at birth46,
inhibited growth of the ovine gastrointestinal tract during the
first half of gestation47 and increased liver weight in fetal
sheep when restricted between 28–78 d gestation48. Reduced
growth of some tissues may be due to increased growth of
other organs, in a selective trade-off depending upon the relative
importance of the organs for the survival of the offspring or due
to the timing of the nutritional insult42. In the case of nutrient
insults during development, it may be beneficial to increase
gut length/capacity to increase lumenal surface area and to
reduce food transit time, therefore increasing the capacity to
absorb nutrients. If such a mechanism exists, the continuedT
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Fig. 2. Intestinal tumour multiplicity and tumour burden. B, colon tumour
number; , small intestine tumour number. *P¼0·041. For details of diets
and procedures, see Materials and methods.
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growth of gut organs may be pre-programmed due to the original
developmental constraints to which the fetus was subjected33.
Although organ growth was altered with folic acid depletion in
utero, overall growth (measured by body mass) of mice was
not affected by folic acid depletion in utero and/or post-weaning.
As observed previously in Apc þ/Min mice49,50, there were
more tumours in the terminal SI when compared with the
proximal SI and the colon. There were no significant effects
of maternal folic acid supply on tumour number, incidence
or size in adult Apc þ/Min mice, indicating that folic acid
depletion during in utero development had no effect on
tumour initiation or tumour growth in these animals. This
may be because the level of folic acid depletion may not
have been sufficiently severe to impact upon tumorigenesis
in the offspring and perhaps further dietary restriction of
another methyl donor may have altered tumorigenesis in
these mice. In the present study, birth weight was not
measured and although offspring from folate-depleted dams
tended to be lighter at weaning this difference was not statisti-
cally significant (P¼0·093). It is not known whether the pups
from folate-depleted dams experienced catch-up growth post-
partum nor do we have any information on the effect, if any,
of such catch-up growth on tumour development.
Female mice had a significantly (P¼0·047) higher number
of total tumours compared with males in the present study.
Previous studies in Apc þ/Min mice have observed differences
in SI tumour number between gender. Steffensen et al.49
reported that male mice had 18 % fewer tumours than
females, whereas Paulsen et al.51 reported that males had
50 % more tumours than females. However, we also observed
a gender*post-weaning diet interaction for total tumour
burden, in which normal folic acid females had a larger
tumour burden than depleted females and both normal and
folic acid-depleted males. These data indicate that a depletion
of folic acid in these female mice was protective against
tumorigenesis. Under the conditions of the current study,
normal folic acid supply appears to be detrimental in respect
of intestinal tumorigenesis in females, but not males. Several
other studies have also indicated that gender can influence
the efficacy of various interventions on intestinal tumorigen-
esis in Apc þ/Min mice. For example, a rye bran-containing
diet increased SI tumour number in female, but not in male
Apc þ/Min mice52 and the addition of a vegetable–fruit mix
to a low fat diet enhanced intestinal polyp multiplicity signifi-
cantly in female Apc þ/Min mice only53. Treadmill running
reduced both intestinal polyp number and size in male but
not in female mice54. This evidence indicates that gender is
an important factor when investigating effects of environmen-
tal factors upon tumorigenesis in the Apc þ/Min mouse model.
Two questions arise from the outcomes observed in this
study: i) why were there more tumours in female mice com-
pared with males? ii) why did females, but not males, respond
to folic acid depletion? Gender-related hormones may have
been one factor influencing the differences in tumour
number between gender in this study. Indeed, ovariectomy
in female Apc þ/Min mice has been observed to increase
Fig. 3. Effects of gender and post-weaning folic acid supply on tumorigenesis in adult Apcþ/Min offspring (- - - -, male; –B–, female). (A) Total tumours (P¼0·077
for gender £ diet interaction; (B) small intestine tumour number (P¼0·075 for gender £ diet interaction; (C) tumour burden (P¼0·028 for gender £ diet interaction);
(D) % of total small tumours (P¼0·047 for gender £ diet interaction). For details of diets and procedures, see Materials and methods.
Gender specific modulation of tumorigenesis 555
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
intestinal tumour number55,56 and subsequent treatment with
17b-oestradiol and coumestrol reduced tumour number similar
to that found in non-ovariectomised control mice, indicating
that female sex hormones can affect tumorigenesis in this
model. However, this does not explain our findings. In contrast
with Weyant et al.’s study55, where oestrogen conferred pro-
tection against more aggressive tumorigenesis in females, we
found enhanced tumorigenesis in intact females compared
with males. This apparent gender effect and the discordant
findings between studies require further investigation.
As summarised in a recent review by Kim 57, inconsistent
findings on effects of altering dietary folate supply on intesti-
nal tumorigenesis have been reported between different
studies. With higher intakes of folic acid within the physio-
logical range, i.e. 8 mg/kg diet, decreased incidence of micro-
scopic and macroscopic neoplasms was observed in DMH
rats17,18. However, azoxymethane-treated rats showed
increased incidence of colonic aberrant crypt foci and tumours
of the large and SI when fed 8 compared with 0 mg folic acid/
kg diet21,22. Two studies used pharmacological concentrations
of folic acid and found that 40 mg folic acid/kg diet increased
tumorigenesis by 40 % compared with controls in DMH-trea-
ted rats18, whereas increasing concentrations of folate up to
20 mg/kg in Apc þ/Min mice led to a dose-dependent linear
decrease in ileal adenoma and aberrant crypt foci23. It has
been hypothesised that timing of folate depletion/supplemen-
tation may be critical in determining the effect on tumorigen-
esis. Song et al.23 investigated the effects of folate depletion in
Apc þ/ –Msh2 – /– mice from both 3 and 6 weeks of age. Mice
depleted from 3 weeks had more tumours compared with
folate-supplemented animals, but folate depletion from 6
weeks of age reduced tumour number. Since tumour initiation
has occurred by 6 (but not 3) weeks of age23, this observation
suggests that folic acid supplementation may be protective
prior to tumour initiation but that folate depletion confers
greater protection once tumour growth has started. Indeed in
the present study, reducing folic acid supply from 4–5
weeks of age reduced tumorigenesis by lowering SI tumour
numbers and increasing the mean percentage of small tumours
in both the SI and colon compared with controls in female
mice. The present study therefore supports the hypothesis
that folic acid depletion post-tumour initiation (4–5 weeks
of age) slows tumour progression, but did not indicate any
beneficial or detrimental effect on tumorigenesis of folic
acid depletion prior to tumour initiation (in utero and until
4–5 weeks of age).
The present study provides evidence that reduced folic acid
supply may be protective against tumour progression in
female Apc þ/Min mice when imposed from 4–5 weeks of
age. This is probably due to reduced availability of folic
acid for DNA synthesis and cell division, thus slowing
tumour growth. Indeed, in Apc þ/Min mice given the che-
motherapeutic drug, 5-fluorouracil, which acts upon thymidy-
late synthase causing a reduction in the conversion of dUMP
to dTMP, folic acid depletion enhanced drug efficacy58.
Further, folate depletion inhibited tumour recovery once
the drug was withdrawn and, 6 weeks after withdrawal,
folate-depleted mice had lower tumour numbers compared
with age-matched controls58. This was possibly due to the
continued depletion of nucleotides slowing tumour cell pro-
liferation.
To our knowledge, this is the first study to test the hypoth-
esis that folic acid depletion in utero and during lactation
could influence tumorigenesis in later life. Although our diet-
ary protocol was successful in reducing folate status whilst
ensuring the production of viable offspring with no detriment
in postnatal growth, there was no evidence that such maternal
folic acid depletion affected tumorigenesis in the offspring.
In contrast, folic acid depletion from weaning (4–5 weeks
of age) may be protective against tumour development in
female, but not in male, Apc þ/Min mice. These observations
support the hypothesis that a critical period of vulnerability
to folic acid supply occurs after tumour initiation, especially
in females. Further studies will be needed to confirm or
refute this gender-specific effect of altered folic acid supply
on intestinal tumour development and, if confirmed, to inves-
tigate the mechanism responsible for the greater sensitivity of
females to this nutritional manipulation.
In summary, the present study shows that: i) there was no
effect of maternal folic acid supply (within the range tested)
on intestinal tumorigenesis; ii) reduced dietary folic acid
supply from weaning inhibited the growth of neoplastic
lesions in female Apc þ/Min mice. The implications of these
findings for the role of folic acid supply in human tumorigen-
esis remain to be established. Fortification (both voluntary and
mandatory) of foods with folic acid is common in North
America and in the UK. Whilst such fortification is likely to
be beneficial for women of reproductive age in lowering the
risk of neural tube defects, the implications for other popu-
lation groups remain less certain. The important observation
by Cole et al.59 that those with a recent history of colorectal
adenomas had a higher risk of having three or more adenomas
and of non-colorectal cancer 3–5 years after being randomised
to 1 mg folic acid/d suggests the need for further research to
ascertain whether raised folic acid intake may increase the
risk of colorectal neoplasia.
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